Sign inJoin waitlistJoin the waitlist

Anuradha Banerjee

Professor · University of California (San Francisco) School of Medicine

Credentials: · · · ·

History

University of California (San Francisco) School of Medicine
Present

Pediatric Hematology Oncology
University of California (San Francisco) School of Medicine
1995–1998
Pediatrics
University of California (San Francisco) School of Medicine
1992–1995
Tulane University
Tulane University School of Medicine
1988–1992

Research

Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial
The Lancet Oncology · 2019 · 409 citations
A phase I trial of the MEK inhibitor selumetinib (AZD6244) in pediatric patients with recurrent or refractory low-grade glioma: a Pediatric Brain Tumor Consortium (PBTC) study
Neuro-Oncology · 2017 · First of 21 authors · 254 citations
Targeted next-generation sequencing of pediatric neuro-oncology patients improves diagnosis, identifies pathogenic germline mutations, and directs targeted therapy
Neuro-Oncology · 2017 · 207 citations

Nalin Gupta
31 papers
Sabine Mueller
25 papers
Michael Prados
20 papers
Cassie Kline
16 papers
David Solomon
16 papers
Tarik Tihan
16 papers
LK
Larry Kun
15 papers
Mitchel Berger
15 papers
Roger Packer
15 papers
Stewart Goldman
15 papers
Arie Perry
14 papers · 1 as a fellow
Daphne Haas-Kogan
14 papers

Grants

Pediatric Clinical Research Center
National Center for Research Resources · M01
Project lead · $92K · University of California, San Francisco
2004–2006

Clinical trials

Alternating Systemic Chemotherapy and Intra-Arterial Melphalan (IAM) Chemotherapy in Children With Intra-Ocular Retinoblastoma
Principal investigator · Terminated · Phase 1
University of California, San Francisco
2014–2019
Phase I/II Trial of Intracerebral IL13-PE38QQR Infusions in Pediatric Patients With Recurrent Malignant Glioma
Principal investigator · Withdrawn · Phase 1, Phase 2
INSYS Therapeutics Inc
Immunotoxin Therapy in Treating Children With Recurrent Malignant Gliomas
Study chair · Withdrawn · Phase 1, Phase 2
Pediatric Brain Tumor Consortium
2005